These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30140203)

  • 1. Phosphoproteomic Alterations of Ionotropic Glutamate Receptors in the Hippocampus of the Ts65Dn Mouse Model of Down Syndrome.
    Gómez de Salazar M; Grau C; Ciruela F; Altafaj X
    Front Mol Neurosci; 2018; 11():226. PubMed ID: 30140203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
    Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
    Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
    Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
    Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Chronic Fluoxetine Treatment of Ts65Dn Mice Rescues Synaptic Vesicular Deficits and Prevents Aberrant Proteomic Alterations.
    Fatemi SH; Otte ED; Folsom TD; Eschenlauer AC; Roper RJ; Aman JW; Thuras PD
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamatergic synaptic deficits in the prefrontal cortex of the Ts65Dn mouse model for Down syndrome.
    Thomazeau A; Lassalle O; Manzoni OJ
    Front Neurosci; 2023; 17():1171797. PubMed ID: 37841687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome.
    Parrini M; Ghezzi D; Deidda G; Medrihan L; Castroflorio E; Alberti M; Baldelli P; Cancedda L; Contestabile A
    Sci Rep; 2017 Dec; 7(1):16825. PubMed ID: 29203796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered signaling pathways underlying abnormal hippocampal synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
    Siarey RJ; Kline-Burgess A; Cho M; Balbo A; Best TK; Harashima C; Klann E; Galdzicki Z
    J Neurochem; 2006 Aug; 98(4):1266-77. PubMed ID: 16895585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological alterations in the hippocampus of the Ts65Dn mouse model for Down Syndrome correlate with structural plasticity markers.
    Villarroya O; Ballestín R; López-Hidalgo R; Mulet M; Blasco-Ibáñez JM; Crespo C; Nacher J; Gilabert-Juan J; Varea E
    Histol Histopathol; 2018 Jan; 33(1):101-115. PubMed ID: 28374408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome.
    Uguagliati B; Al-Absi AR; Stagni F; Emili M; Giacomini A; Guidi S; Nyengaard JR; Bartesaghi R
    Hippocampus; 2021 Apr; 31(4):435-447. PubMed ID: 33464704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome.
    Di Filippo M; Tozzi A; Ghiglieri V; Picconi B; Costa C; Cipriani S; Tantucci M; Belcastro V; Calabresi P
    Biol Psychiatry; 2010 Apr; 67(7):666-71. PubMed ID: 19818432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
    Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
    Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Potassium and Cation Channels in Hippocampal Abnormalities of Embryonic Ts65Dn and Tc1 Trisomic Mice.
    Stern S; Segal M; Moses E
    EBioMedicine; 2015 Sep; 2(9):1048-62. PubMed ID: 26501103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
    Stagni F; Giacomini A; Emili M; Trazzi S; Guidi S; Sassi M; Ciani E; Rimondini R; Bartesaghi R
    Neuroscience; 2016 Oct; 333():277-301. PubMed ID: 27457036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide miR-155 and miR-802 target gene identification in the hippocampus of Ts65Dn Down syndrome mouse model by miRNA sponges.
    Bofill-De Ros X; Santos M; Vila-Casadesús M; Villanueva E; Andreu N; Dierssen M; Fillat C
    BMC Genomics; 2015 Nov; 16():907. PubMed ID: 26546125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear Reorganization in Hippocampal Granule Cell Neurons from a Mouse Model of Down Syndrome: Changes in Chromatin Configuration, Nucleoli and Cajal Bodies.
    Puente-Bedia A; Berciano MT; Tapia O; Martínez-Cué C; Lafarga M; Rueda N
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33514010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered intrinsic and network properties of neocortical neurons in the Ts65Dn mouse model of Down syndrome.
    Cramer NP; Xu X; F Haydar T; Galdzicki Z
    Physiol Rep; 2015 Dec; 3(12):. PubMed ID: 26702072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GABA
    Block A; Ahmed MM; Rueda N; Hernandez MC; Martinez-Cué C; Gardiner KJ
    Neuroscience; 2018 Feb; 372():192-212. PubMed ID: 29292072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreasing the Expression of GABA
    Vidal V; García-Cerro S; Martínez P; Corrales A; Lantigua S; Vidal R; Rueda N; Ozmen L; Hernández MC; Martínez-Cué C
    Mol Neurobiol; 2018 Jun; 55(6):4745-4762. PubMed ID: 28717969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term voluntary running modifies the levels of proteins of the excitatory/inhibitory system and reduces reactive astrogliosis in the brain of Ts65Dn mouse model for Down syndrome.
    Kida E; Walus M; Albertini G; Golabek AA
    Brain Res; 2021 Sep; 1766():147535. PubMed ID: 34043998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome.
    Costa AC; Grybko MJ
    Neurosci Lett; 2005 Jul; 382(3):317-22. PubMed ID: 15925111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.